In post 9 of the series, we explained our methods for identifying PK data.
and in the following posts, 9a to 9e
we explained that the PK data seen by regulators lacked numbers and details, for example…
Exploring regulatory data sets of the Comirnaty vaccine - Second part
A summary of posts
